Saturday, March 09, 2019 2:37:41 PM
A few things that make you question HOW this is a .007 sub penny stock..
1. Multiple Pharm prodrug Patents until 2034
2. Licensing agreements with another Pharm company worth 10's of millions 9/2018
3. Continued verifiable ongoing research in Denmark, Germany, and The USA. 2/2019
4. Military research involvement 11/2018
5. Samuel Denmeade, John Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Department of Defense Prostate Cancer Research Program/Military Clinical Pipeline
6. Sabby Hedge fund, Hal Mintz - ownership investment 11/2018
7. JLL one of the world's leading investment managers, Connor Flannery - ownership investment 11/2018
8. Soren Christensen - University of Copenhagen - Continued research latest publication submitted in Dec 2018 Published in January 2019.
9. FDA - Orphan Drug Status for Mipsagargin
10. WHO’s International Nonproprietary Name group or the INN recommended the generic name “mipsagargin” for Inspyr's lead compound G-202
Going to take off with the impending SEC filings!!
$NSPX STRONGER
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM